Extended-phase anticoagulation for pediatric venous thromboembolism after EINSTEIN Jr

Nathan Wilken, Jun Teruya · 2026

Read Extended-phase anticoagulation for pediatric venous thromboembolism after EINSTEIN Jr by Nathan Wilken, Jun Teruya (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13351711.txt.

Description

Nathan Wilken and Jun Teruya review extended blood-thinner treatment for children with venous thromboembolism in 2026, in light of the EINSTEIN Jr trial. Deciding whether to continue beyond the first 3 months is one of the hardest calls in this field. Adult data show fewer repeat clots but more bleeding with longer treatment.

In EINSTEIN Jr, rivaroxaban matched standard care for acute clots in children, with repeat clots in 1 percent versus 3 percent over 1 to 3 months and low bleeding in both groups. Wilken and Teruya weigh how far adult lessons on longer and lower-dose plans carry into childhood care. They stress that best length and strength for children remain poorly defined.

Catalog record

CREATORNathan Wilken, Jun Teruya
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE12569
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13351711

Browse the full library · About the Tower of Babel